Furthermore, pharmacological inhibition of TREM-1 has been shown to reduce inflammation and lipid accumulation in diet-induced nonalcoholic fatty liver disease (NAFLD) models. The gene discussed is TREM1; the disease is metabolic dysfunction-associated steatotic liver disease.